Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$233.08 - $265.59 $109,314 - $124,561
-469 Reduced 6.66%
6,574 $1.63 Million
Q2 2023

Aug 07, 2023

SELL
$224.99 - $256.14 $4.24 Million - $4.83 Million
-18,844 Reduced 72.79%
7,043 $1.69 Million
Q1 2023

May 08, 2023

SELL
$239.75 - $277.0 $626,946 - $724,355
-2,615 Reduced 9.17%
25,887 $6.52 Million
Q4 2022

Jan 31, 2023

SELL
$241.42 - $282.29 $228,383 - $267,046
-946 Reduced 3.21%
28,502 $7.57 Million
Q3 2022

Oct 21, 2022

SELL
$247.06 - $1507.4 $94,376 - $575,826
-382 Reduced 1.28%
29,448 $7.61 Million
Q2 2022

Aug 02, 2022

BUY
$237.11 - $299.66 $912,636 - $1.15 Million
3,849 Added 14.81%
29,830 $7.56 Million
Q1 2022

May 06, 2022

BUY
$257.27 - $315.76 $154,362 - $189,456
600 Added 2.36%
25,981 $7.62 Million
Q4 2021

Feb 07, 2022

BUY
$292.08 - $329.01 $1.93 Million - $2.17 Million
6,595 Added 35.11%
25,381 $8.35 Million
Q3 2021

Oct 29, 2021

BUY
$272.21 - $332.43 $681,886 - $832,737
2,505 Added 15.39%
18,786 $5.72 Million
Q2 2021

Aug 09, 2021

BUY
$225.08 - $271.69 $1.14 Million - $1.37 Million
5,050 Added 44.96%
16,281 $4.37 Million
Q1 2021

May 06, 2021

SELL
$212.38 - $245.9 $2.62 Million - $3.04 Million
-12,352 Reduced 52.38%
11,231 $2.53 Million
Q4 2020

Feb 11, 2021

BUY
$212.5 - $245.46 $3.18 Million - $3.67 Million
14,950 Added 173.17%
23,583 $5.24 Million
Q3 2020

Nov 05, 2020

BUY
$177.16 - $215.33 $393,118 - $477,817
2,219 Added 34.6%
8,633 $1.86 Million
Q2 2020

Aug 04, 2020

BUY
$128.7 - $176.83 $825,481 - $1.13 Million
6,414 New
6,414 $1.13 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $177B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Twin Capital Management Inc Portfolio

Follow Twin Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Twin Capital Management Inc with notifications on news.